Visiopharm: Join us on 5 September in Basel, Switzerland for our breakfast symposium at the 2022 European Congress of Pathology (ECP). Learn more about how existing manual processes in the histopathology lab can be optimized to introduce...

Visiopharm are pleased to announce the novel launch of an automated, and IVDR certified, AI-driven digital pathology workflow for University Medical Center Utrecht (UMCU) in the Netherlands. The workflow will be based on existing and new next...

March 21, 2022: Today, Visiopharm launches Qualitopix™ for AI-driven standardization of tissue staining at USCAP 2022 is introducing its novel and unique Qualitopix™ solution to delegates at the United States and Canadian Academy of...

CIO Applications recently sat down with our founder and CEO Michael Grunkin. The technology print magazine focuses on usage of various tech start ups. In the latest issue the spotlight was placed on the marketplace of machine learning...

Visiopharm’s quantitative image analysis software suite uniquely offers a secure, scalable, agnostic platform that helps pathologists and researchers alike address the quality and cost challenges in drug discovery and cancer...

During the event, we will be showcasing our entire digital pathology portfolio. Here we are particularly proud to share our work in advancing PD-L1 testing based on the patented VirtualTripleStaining™ and its utility in automated assessment...